No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
Identifieur interne : 000446 ( Main/Exploration ); précédent : 000445; suivant : 000447No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
Auteurs : Salaheddin M. Mahmud [Canada] ; Paul Van Caeseele ; Gregory Hammond ; Carol Kurbis ; Tim Hilderman ; Lawrence ElliottSource :
- Emerging infectious diseases [ 1080-6059 ] ; 2012.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Manitoba (épidémiologie), Mâle (MeSH), Nourrisson (MeSH), Pandémies (MeSH), Sous-type H1N1 du virus de la grippe A (immunologie), Sujet âgé (MeSH), Vaccins antigrippaux (administration et posologie), Études cas-témoins (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A.
- prévention et contrôle : Grippe humaine.
- épidémiologie : Grippe humaine, Manitoba.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Nourrisson, Pandémies, Sujet âgé, Études cas-témoins.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Case-Control Studies (MeSH), Child (MeSH), Child, Preschool (MeSH), Female (MeSH), Humans (MeSH), Infant (MeSH), Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Manitoba (epidemiology), Middle Aged (MeSH), Pandemics (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Manitoba.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human.
- Adolescent, Adult, Aged, Case-Control Studies, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Pandemics, Young Adult.
Abstract
We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008-09 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic. Data were obtained from a provincewide population-based immunization registry and laboratory-based influenza surveillance system. The test-negative case-control study included 831 case-patients with confirmed influenza A(H1N1)pdm09 virus infection and 2,479 controls, participants with test results negative for influenza A and B viruses. For the association of TIV receipt with influenza A(H1N1)pdm09 virus infection, the fully adjusted odds ratio was 1.0 (95% CI 0.7-1.4). Among case-patients, receipt of 2008-09 TIV was associated with a statistically nonsignificant 49% reduction in risk for hospitalization. In agreement with study findings outside Canada, our study in Manitoba indicates that the 2008-09 TIV neither increased nor decreased the risk for infection with influenza A(H1N1)pdm09 virus.
DOI: 10.3201/eid1805.111596
PubMed: 22516189
PubMed Central: PMC3358049
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.</title><author><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><affiliation wicri:level="4"><nlm:affiliation>University of Manitoba, Winnipeg, Manitoba, Canada. salah.mahmud@gmail.com</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name></author><author><name sortKey="Hammond, Gregory" sort="Hammond, Gregory" uniqKey="Hammond G" first="Gregory" last="Hammond">Gregory Hammond</name></author><author><name sortKey="Kurbis, Carol" sort="Kurbis, Carol" uniqKey="Kurbis C" first="Carol" last="Kurbis">Carol Kurbis</name></author><author><name sortKey="Hilderman, Tim" sort="Hilderman, Tim" uniqKey="Hilderman T" first="Tim" last="Hilderman">Tim Hilderman</name></author><author><name sortKey="Elliott, Lawrence" sort="Elliott, Lawrence" uniqKey="Elliott L" first="Lawrence" last="Elliott">Lawrence Elliott</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22516189</idno><idno type="pmid">22516189</idno><idno type="doi">10.3201/eid1805.111596</idno><idno type="pmc">PMC3358049</idno><idno type="wicri:Area/Main/Corpus">000450</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000450</idno><idno type="wicri:Area/Main/Curation">000450</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000450</idno><idno type="wicri:Area/Main/Exploration">000450</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.</title><author><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name><affiliation wicri:level="4"><nlm:affiliation>University of Manitoba, Winnipeg, Manitoba, Canada. salah.mahmud@gmail.com</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Manitoba, Winnipeg, Manitoba</wicri:regionArea><orgName type="university">Université du Manitoba</orgName><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name></author><author><name sortKey="Hammond, Gregory" sort="Hammond, Gregory" uniqKey="Hammond G" first="Gregory" last="Hammond">Gregory Hammond</name></author><author><name sortKey="Kurbis, Carol" sort="Kurbis, Carol" uniqKey="Kurbis C" first="Carol" last="Kurbis">Carol Kurbis</name></author><author><name sortKey="Hilderman, Tim" sort="Hilderman, Tim" uniqKey="Hilderman T" first="Tim" last="Hilderman">Tim Hilderman</name></author><author><name sortKey="Elliott, Lawrence" sort="Elliott, Lawrence" uniqKey="Elliott L" first="Lawrence" last="Elliott">Lawrence Elliott</name></author></analytic><series><title level="j">Emerging infectious diseases</title><idno type="eISSN">1080-6059</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Case-Control Studies (MeSH)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Infant (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Manitoba (epidemiology)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Manitoba (épidémiologie)</term><term>Mâle (MeSH)</term><term>Nourrisson (MeSH)</term><term>Pandémies (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sujet âgé (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Études cas-témoins (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Manitoba</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Manitoba</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Case-Control Studies</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Humans</term><term>Infant</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Pandémies</term><term>Sujet âgé</term><term>Études cas-témoins</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008-09 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic. Data were obtained from a provincewide population-based immunization registry and laboratory-based influenza surveillance system. The test-negative case-control study included 831 case-patients with confirmed influenza A(H1N1)pdm09 virus infection and 2,479 controls, participants with test results negative for influenza A and B viruses. For the association of TIV receipt with influenza A(H1N1)pdm09 virus infection, the fully adjusted odds ratio was 1.0 (95% CI 0.7-1.4). Among case-patients, receipt of 2008-09 TIV was associated with a statistically nonsignificant 49% reduction in risk for hospitalization. In agreement with study findings outside Canada, our study in Manitoba indicates that the 2008-09 TIV neither increased nor decreased the risk for infection with influenza A(H1N1)pdm09 virus.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22516189</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2012</Year><Month>May</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.</ArticleTitle><Pagination><MedlinePgn>801-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid1805.111596</ELocationID><Abstract><AbstractText>We conducted a population-based study in Manitoba, Canada, to investigate whether use of inactivated trivalent influenza vaccine (TIV) during the 2008-09 influenza season was associated with subsequent infection with influenza A(H1N1)pdm09 virus during the first wave of the 2009 pandemic. Data were obtained from a provincewide population-based immunization registry and laboratory-based influenza surveillance system. The test-negative case-control study included 831 case-patients with confirmed influenza A(H1N1)pdm09 virus infection and 2,479 controls, participants with test results negative for influenza A and B viruses. For the association of TIV receipt with influenza A(H1N1)pdm09 virus infection, the fully adjusted odds ratio was 1.0 (95% CI 0.7-1.4). Among case-patients, receipt of 2008-09 TIV was associated with a statistically nonsignificant 49% reduction in risk for hospitalization. In agreement with study findings outside Canada, our study in Manitoba indicates that the 2008-09 TIV neither increased nor decreased the risk for infection with influenza A(H1N1)pdm09 virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahmud</LastName><ForeName>Salaheddin M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>University of Manitoba, Winnipeg, Manitoba, Canada. salah.mahmud@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Caeseele</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Kurbis</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hilderman</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008350" MajorTopicYN="N" Type="Geographic">Manitoba</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22516189</ArticleId><ArticleId IdType="doi">10.3201/eid1805.111596</ArticleId><ArticleId IdType="pmc">PMC3358049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biometrics. 1988 Dec;44(4):1157-68</Citation><ArticleIdList><ArticleId IdType="pubmed">3233252</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):749-59</Citation><ArticleIdList><ArticleId IdType="pubmed">15386720</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1994 Oct;84(10):1666-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7943493</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1997 Sep;35(9):932-47</Citation><ArticleIdList><ArticleId IdType="pubmed">9298082</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2008 Jul;34(ACS-3):1-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18802991</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jul 10;325(5937):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">19465683</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;339:b3928</Citation><ArticleIdList><ArticleId IdType="pubmed">19808768</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19910912</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;339:b4972</Citation><ArticleIdList><ArticleId IdType="pubmed">19934198</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Dec 15;49(12):1801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19911946</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Dec 15;49(12):1811-20</Citation><ArticleIdList><ArticleId IdType="pubmed">19911964</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Dec;47(12):3805-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19794033</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009;4(12):e8431</Citation><ArticleIdList><ArticleId IdType="pubmed">20037716</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Dec 31;361(27):2628-36</Citation><ArticleIdList><ArticleId IdType="pubmed">20042754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Dec 19;374(9707):2072-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19913290</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Feb 23;182(3):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20093297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 6;375(9717):801-2; author reply 802-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20206765</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Mar 9;182(4):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">20159893</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2010 Apr;16(4):719-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20350398</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Apr;7(4):e1000258</Citation><ArticleIdList><ArticleId IdType="pubmed">20386731</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20388894</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(5):e10722</Citation><ArticleIdList><ArticleId IdType="pubmed">20502705</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Cell Biol. 2010 Aug;88(4):589-93</Citation><ArticleIdList><ArticleId IdType="pubmed">20651829</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010;15(28). pii: 19616</Citation><ArticleIdList><ArticleId IdType="pubmed">20650055</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Oct 4;28(42):6852-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20723626</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Nov 3;28(47):7460-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20875486</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Dec 15;51(12):1370-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21067351</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Dec 15;51(12):1380-2</Citation><ArticleIdList><ArticleId IdType="pubmed">21067354</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Nov 25;15(47). pii: 19722</Citation><ArticleIdList><ArticleId IdType="pubmed">21144441</ArticleId></ArticleIdList></Reference><Reference><Citation>Gac Sanit. 2011 Jan-Feb;25(1):23-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21334788</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Mar 21;29(14):2613-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21292008</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2011 May;26(5):546-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21203857</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Aug 26;29(37):6419-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21473950</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2002 Nov-Dec;93 Suppl 2:S15-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12580385</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1992 May 1;135(9):1019-28</Citation><ArticleIdList><ArticleId IdType="pubmed">1595688</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Manitoba</li></region><settlement><li>Winnipeg</li></settlement><orgName><li>Université du Manitoba</li></orgName></list><tree><noCountry><name sortKey="Elliott, Lawrence" sort="Elliott, Lawrence" uniqKey="Elliott L" first="Lawrence" last="Elliott">Lawrence Elliott</name><name sortKey="Hammond, Gregory" sort="Hammond, Gregory" uniqKey="Hammond G" first="Gregory" last="Hammond">Gregory Hammond</name><name sortKey="Hilderman, Tim" sort="Hilderman, Tim" uniqKey="Hilderman T" first="Tim" last="Hilderman">Tim Hilderman</name><name sortKey="Kurbis, Carol" sort="Kurbis, Carol" uniqKey="Kurbis C" first="Carol" last="Kurbis">Carol Kurbis</name><name sortKey="Van Caeseele, Paul" sort="Van Caeseele, Paul" uniqKey="Van Caeseele P" first="Paul" last="Van Caeseele">Paul Van Caeseele</name></noCountry><country name="Canada"><region name="Manitoba"><name sortKey="Mahmud, Salaheddin M" sort="Mahmud, Salaheddin M" uniqKey="Mahmud S" first="Salaheddin M" last="Mahmud">Salaheddin M. Mahmud</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000446 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000446 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22516189
|texte= No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22516189" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |